- Published on
Symptoms and Signs – Differential Diagnosis of Iron Overload
• Aceruloplasminemia
• African dietary iron overload
• Associated with neurologic abnormalities
• Atransferrinemia
• Autosomal dominant hemochromatosis, ferroprotein associated (type 4)
• Cerebrohepatorenal syndrome
• Chronic liver disease
• DMT1-associated hemochromatosis
• Friedreich’s ataxia
• GRACILE (Fellman) syndrome
• GRACILE (growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death)
• Hemojuvelin associated (type 2A)
• Hepcidin associated (type 2B)
• Hereditary hemochromatosis
• HFE associated (type 1)
• Idiopathic pulmonary hemosiderosis
• Inadvertent iron overload from therapeutic injections
• Insulin resistance–associated hepatic iron overload
• Iron-loading anemias (refractory anemias with hypercellular erythroid marrow)
• Juvenile hemochromatosis (type 2)
• Medicinal iron ingestion
• Neonatal hemochromatosis
• Neuroferritinopathy
• Non–HFE associated
• Pantothenate kinase–associated neurodegeneration (formerly called Hallervorden-Spatz syndrome)
• Parenteral iron overload
• Porphyria cutanea tarda
• Renal hemosiderosis
• Transferrin receptor 2 associated (type 3)
• Transfusional iron overload
• Trichohepatoenteric syndrome
• Aceruloplasminemia
• African dietary iron overload
• Associated with neurologic abnormalities
• Atransferrinemia
• Autosomal dominant hemochromatosis, ferroprotein associated (type 4)
• Cerebrohepatorenal syndrome
• Chronic liver disease
• DMT1-associated hemochromatosis
• Friedreich’s ataxia
• GRACILE (Fellman) syndrome
• GRACILE (growth retardation, aminoaciduria, cholestasis, iron overload, lactic acidosis, and early death)
• Hemojuvelin associated (type 2A)
• Hepcidin associated (type 2B)
• Hereditary hemochromatosis
• HFE associated (type 1)
• Idiopathic pulmonary hemosiderosis
• Inadvertent iron overload from therapeutic injections
• Insulin resistance–associated hepatic iron overload
• Iron-loading anemias (refractory anemias with hypercellular erythroid marrow)
• Juvenile hemochromatosis (type 2)
• Medicinal iron ingestion
• Neonatal hemochromatosis
• Neuroferritinopathy
• Non–HFE associated
• Pantothenate kinase–associated neurodegeneration (formerly called Hallervorden-Spatz syndrome)
• Parenteral iron overload
• Porphyria cutanea tarda
• Renal hemosiderosis
• Transferrin receptor 2 associated (type 3)
• Transfusional iron overload
• Trichohepatoenteric syndrome
0 Comments
